News

Ortho Clinical Diagnostics (OCD) has opened a new manufacturing facility in Pencoed, Wales. The new, 110,000 square feet facility would employ over 350 people in manufacturing operations, quality,

Aclasta (zoledronic acid 5 mg) has been approved in the European Union (EU) to treat men and postmenopausal women with osteoporosis. It is caused by long-term use of

FDA has issued a notice of intent to Immucor to revoke its biologics license, with respect to its Reagent Red Blood Cells and Anti-E Blood Grouping Reagent product.

CHMP has issued a positive opinion supporting Laboratoires Pierre’ approval for Javlor. Also, it is recommending to grant marketing authorisation as monotherapy in metastatic treatment of bladder cancer.

Radiant Research is enrolling subjects and establishing operational plans for upcoming H1N1 vaccine trials. Michael Kritschgau, Vice President of Radiant, said: “We have over a million subjects in

Miraculins has finalized a research collaboration agreement with Diagnostic Technologies. The company has also announced the execution of a cooperation and project funding agreement with DTL and CIIRDF

CHMP of the European Medicines Agency (EMEA) has issued a positive opinion about Boehringer Ingelheim’s Mirapexin/Sifrol (pramipexole). It has recommended the approval of once daily formulation for Mirapexin/Sifrol

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead’s Marketing Authorisation Application for aztreonam lysine 75mg powder and solvent for nebuliser

Antigenics has announced that Brain Tumor Research Center at the University of California (UCSF), has expanded phase-II clinical trial of Oncophage (vitespen) for glioma. The trial will now